Home › Breast Cancer › New Jersey
Breast Cancer clinical trials in New Jersey
94 studies for Breast Cancer are looking for participants at sites in New Jersey.
Cities in New Jersey
- Edison70 studies
- Newark17 studies
- Elizabeth11 studies
- Clifton11 studies
- Trenton11 studies
- Camden7 studies
- Brick6 studies
- Paterson6 studies
- Toms River4 studies
- Jersey City3 studies
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
- Rutgers Cancer Institute of New Jersey, New Brunswick
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT05696626A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)
- Astera Cancer Care East Brunswick, East Brunswick
- Rutgers Cancer Institute of New Jersey, New Brunswick
RecruitingPhase 3
Ages 18 and older · Women · Updated Nov 12, 2026 · NCT07541079S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- Morristown Medical Center, Morristown
- Overlook Hospital, Summit
- Holy Name Hospital, Teaneck
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT03418961A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RecruitingPhase 3
Ages 18 to 75 · Women · Updated Nov 10, 2026 · NCT06144164A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
- Memorial Sloan Kettering Cancer Center Basking Ridge, Basking Ridge
- Summit Medical Group, Florham Park
- Memorial Sloan Kettering Cancer Center Monmouth, Middletown
- and 1 more
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT06827236A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Hackensack Univ Medical Center (HUMC) ( Site 0007), Hackensack
- Rutgers Cancer Institute of New Jersey ( Site 0076), New Brunswick
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT06966700Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
- Cooper Health, Camden
- Rutgers, New Brunswick
Recruiting
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07214532A Study of Different Skin Care Approaches to Prevent Skin Reactions in People With Breast Cancer Receiving Radiation Therapy After Mastectomy
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
RecruitingPhase 2
Ages 18 and older · Women · Updated Nov 5, 2026 · NCT07918989Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
- Rutgers Cancer Institute, New Brunswick
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT06982521A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Jefferson Health - Cherry Hill, Cherry Hill
- Sidney Kimmel Cancer Center - Washington Township, Sewell
- Atlantic Health System Overlook Medical Center, Summit
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07174336A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
- Astera Cancer Care East Brunswick, East Brunswick
- Summit Medical Group, Florham Park
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06790693E-Mindfulness Approaches for Living After Breast Cancer
- Ocean University Medical Center, Brick
- Cooper Hospital University Medical Center, Camden
- AtlantiCare Health Park-Cape May Court House, Cape May Court House
- and 14 more
RecruitingPhase 3
Ages 18 to 50 · All sexes · Updated Nov 4, 2026 · NCT06748222Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RecruitingObservational study
Ages 18 and older · Women · Updated Nov 4, 2026 · NCT05590949Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Englewood Hospital and Medical Center, Englewood
- Hackettstown Medical Center, Hackettstown
- Morristown Medical Center, Morristown
- and 7 more
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Nov 4, 2026 · NCT05334069Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- MD Anderson Cancer Center at Cooper- Two Cooper Plaza, Camden
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT05579366Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Englewood Hospital and Medical Center, Englewood
- CentraState Medical Center, Freehold
- Hackettstown Medical Center, Hackettstown
- and 5 more
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06418204Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- Cooper Hospital University Medical Center, Camden
- Jefferson Cherry Hill Hospital, Cherry Hill
- Trinitas Hospital and Comprehensive Cancer Center - Williamson Street Campus, Elizabeth
- and 21 more
RecruitingPhase 3
Ages 18 to 60 · Women · Updated Nov 4, 2026 · NCT05879926A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Cancer
- Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent Only), Middletown
- Memorial Sloan Kettering Bergen (Consent Only), Montvale
Recruiting
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07218250A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
- John Theurer Cancer Center at Hackensack University Medical Center ( Site 0001), Hackensack
- Rutgers Cancer Institute of New Jersey ( Site 0033), New Brunswick
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07060807To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer
- Astera Cancer Care East Brunswick, East Brunswick
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07368998MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
Recruiting
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT06954337The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
- Englewood Hospital, Englewood
- Capital Health Medical Center - Hopewell, Pennington
- Penn Medicine - Princeton Health, Plainsboro
RecruitingPhase 3
Ages 60 and older · All sexes · Updated Nov 2, 2026 · NCT06377852ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
- Summit Medical Group PA, Florham Park
- Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Livingston
- Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Long Branch
- and 4 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT07173751A Study of Skipping Radiation Therapy in People With Breast Cancer
- Memorial Sloan Kettering at Basking Ridge (All protocol activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
Recruiting
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT07895511A Phase 1 Study of LNCB74 in Advanced Solid Tumors
- John Theurer Cancer Ctr at Hackensack Univ. Med Ctr., Hackensack
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT06774963A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
- Astera Cancer Care (Formerly Regional Cancer Care Associates), East Brunswick
- Medical Oncology Hematology Associates, Newark
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT07102381A Study of a Side Effects and Resource Navigation Program for People With Cancer
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
Recruiting
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT07646847KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
- Rutgers Cancer Institute, New Brunswick
- RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT05483491A Study of 68Ga-FAPI Breast PET/MRI Scans in People With Breast Cancer
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT07899892EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
- John Theurer Cancer Center, Hackensack
- Rutgers Cancer Institute of New Jersey, New Brunswick
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT06401421A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
- Rutgers Cancer Institute of New Jersey, New Brunswick
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT07100106A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
- START New Jersey, LLC, East Brunswick
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 22, 2026 · NCT07383506A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 22, 2026 · NCT07287995Factors Associated With Breast Cancer Risks and Outcomes
- Memorial Sloan Kettering Cancer Center Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RecruitingObservational study
Ages 18 and older · Women · Updated Oct 22, 2026 · NCT07294703Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)
- Rutgers Cancer Institute of New Jersey ( Site 0052), New Brunswick
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 21, 2026 · NCT06686394A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
- Hackensack University Medical Center, Hackensack
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 19, 2026 · NCT07062965Rutgers University Study of the Genetics of Breast Cancer.
- Rutgers University, Piscataway
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Oct 16, 2026 · NCT06773897Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 44 · Women · Updated Oct 16, 2026 · NCT00823654A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer or Malignant Peritoneal Mesothelioma
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 15, 2026 · NCT06623396Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- START - New Jersey, East Brunswick
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 13, 2026 · NCT06293898From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.